Takeda Pharmaceutical Files 6-K

TL;DR

Takeda filed a 6-K on 7/9/24, confirming its foreign private issuer status and Tokyo HQ.

AI Summary

Takeda Pharmaceutical Company Limited filed a Form 6-K on July 9, 2024, reporting information as a foreign private issuer. The filing indicates Takeda's principal executive offices are located in Tokyo, Japan, and confirms they file annual reports under Form 20-F.

Why It Matters

This filing serves as an update for investors regarding Takeda's status as a foreign private issuer and its reporting obligations with the SEC.

Risk Assessment

Risk Level: low — This is a routine administrative filing confirming the company's reporting status and location.

Key Numbers

• 001-38757 — SEC File Number (Identifies Takeda's registration with the SEC.)

Key Players & Entities

• Takeda Pharmaceutical Company Limited (company) — Registrant
• 001-38757 (dollar_amount) — SEC File Number
• 20240709 (date) — Filing Date

FAQ

Filing Documents

• form6k_070924.htm (6-K) — 33KB
• 0001395064-24-000121.txt ( ) — 34KB

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TAKEDA PHARMACEUTICAL COMPANY LIMITED Date July 9, 2024 By s Norimasa Takeda Norimasa Takeda Chief Accounting Officer and Corporate Controller News Release Takeda Completed Issuance of New Shares and Disposal of Treasury Shares under the Long-Term Incentive Plan for Company Group Employees Outside of Japan with Partial Forfeiture of Rights Granted to Allottees Osaka, JAPAN, July 9, 2024 – Takeda Pharmaceutical Company Limited ("Company") today announced that it completed the issuance of new shares and disposal of treasury shares ("Issuance of Shares") on July 8, 2024, under the Long-Term Incentive Plan for the Company Group employees outside of Japan. In addition, the number of new shares originally planned, and other relevant figures, have been changed due to a partial forfeiture of rights granted to previously planned allotees, as outlined below. For details about the Issuance of Shares, please refer to the announcement dated June 11, 2024, "Notice Concerning Issuance of New Shares and Disposal of Treasury Shares under the Long-Term Incentive Plan for Company Group Employees Outside of Japan". 1. Changes in Outline of Issuance of Shares (Changes are underlined) After the change Before the change (1) Payment date July 8, 2024 July 8, 2024 (2) Type and number of shares to be issued and disposed of 15,846,346 ordinary shares of the Company, which is the total of the following (i) 8,518,884 new shares and (ii) 7,327,462 treasury shares. 15,905,936 ordinary shares of the Company, which is the total of the following (i) 8,578,474 new shares and (ii) 7,327,462 treasury shares. (3) Issuance and disposal price 4,241 yen per share 4,241 yen per share (4) Total value of shares to be issued and disposed of 67,204,353,386 yen 67,457,074,576 yen (

View Full Filing

View this 6-K filing on SEC EDGAR